Navigation Links
Merck Says Januvia Effective In Type 2 Diabetes

Merck & Co Inc has said that Januvia, its oral, once-daily medicine for type 2 diabetes has shown promise in combating the disease and had significantly reduced //blood sugar levels. This was true when the drug was used alone or in conjunction with two commonly used therapies (metformin or pioglitazone).

Merck presented the results of the Phase III trials at the American Diabetes Association's annual meeting. Treatment with Januvia was also found to improve measures of beta cell function.

Beta cells are found in pancreas and are responsible for producing and releasing insulin. The deficiency of this hormone causes diabetes. Merck said that in the studies, "Januvia had an overall incidence of side effects comparable to placebo and was generally well tolerated."


'"/>




Page: 1

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
4. Judgment In Favor Of Merck For Vioxx Drug
5. Merck, ICMR to conduct joint trials on cervical cancer vaccine
6. Merck in the Dock Due To Vioxx
7. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
8. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
9. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
10. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
11. Ranbaxy in Fray to Buy Mercks Generic Drugs Unit
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the problem ... on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription ... fatal overdoses in male populations.(1) , The proportion of women using illicit drugs is ...
(Date:2/27/2017)... ... 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working ... nun. Now, she writes about God, when she isn’t swimming as a performing mermaid. , ... is BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is ... team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... --  Fourth-quarter 2016 revenues of ... to top end of guidance ... in fourth-quarter 2016 associated with the write-down of goodwill ... reporting unit Fourth-quarter reported ... Full-year 2016 reported $14.48 diluted (GAAP) loss per share ...
(Date:2/27/2017)... 27, 2017 Mederi Therapeutics today announced ... representing 2468 patients who received  Stretta Therapy  to ... " Systematic Review and Meta-Analysis of Controlled and ... Treatment of Gastroesophageal Reflux Disease ", was published in ... Fass , MD, head of the Esophageal and ...
(Date:2/27/2017)... Feb. 27, 2017   Vitasome ® Labs ... supplements using its groundbreaking new liposome technology. Whereas vitamins ... potency through digestion per Physician,s Desk Reference , ... problem of nutritional waste and are scientifically formulated to: ... processes Improve bioavailability with a vastly ...
Breaking Medicine Technology: